Menu
sharewise is moving On the weekend of 22/23 August the new sharewise becomes the main site. Have a look now and tell us what you miss. Go to the new sharewise What changes
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Search results

Royalty Pharma (RPRX) Tops Q2 Earnings and Revenue EstimatesPhoto, wide shot, wide-angle lens,  Mental health care service, Midday, harsh overhead sunlight, directional sunlightt, photo by Art Wolfe: https://img.midjourneyapi.xyz/temp/7ce3b930-5e2a-4215-b686-0ad0eb0b922a.png
Royalty Pharma (RPRX) Tops Q2 Earnings and Revenue Estimates

Royalty Pharma (RPRX) came out with quarterly earnings of $1.32 per share, beating the Zacks Consensus Estimate of $1.27 per share. This compares to earnings of $1.14 per share a year ago. These

J&J Snack Foods (JJSF) Beats Q3 Earnings and Revenue Estimates
J&J Snack Foods (JJSF) Beats Q3 Earnings and Revenue Estimates

J&J Snack Foods (JJSF) came out with quarterly earnings of $1.96 per share, beating the Zacks Consensus Estimate of $1.81 per share. This compares to earnings of $2 per share a year ago. These

New York Times Co. (NYT) Tops Q2 Earnings and Revenue Estimates
New York Times Co. (NYT) Tops Q2 Earnings and Revenue Estimates

New York Times Co. (NYT) came out with quarterly earnings of $0.69 per share, beating the Zacks Consensus Estimate of $0.67 per share. This compares to earnings of $0.58 per share a year ago. These

LCI (LCII) Q2 Earnings Top Estimates
LCI (LCII) Q2 Earnings Top Estimates

LCI (LCII) came out with quarterly earnings of $2.7 per share, beating the Zacks Consensus Estimate of $2.63 per share. This compares to earnings of $2.39 per share a year ago. These figures are

Kyndryl Holdings, Inc. (KD) Reports Q1 Loss, Lags Revenue Estimates
Kyndryl Holdings, Inc. (KD) Reports Q1 Loss, Lags Revenue Estimates

Kyndryl Holdings, Inc. (KD) came out with a quarterly loss of $0.12 per share versus the Zacks Consensus Estimate of a loss of $0.08. This compares to earnings of $0.37 per share a year ago. These

Griffon (GFF) Q3 Earnings and Revenues Beat Estimates
Griffon (GFF) Q3 Earnings and Revenues Beat Estimates

Griffon (GFF) came out with quarterly earnings of $1.51 per share, beating the Zacks Consensus Estimate of $1.33 per share. This compares to earnings of $1.5 per share a year ago. These figures are

Innoviz Technologies Ltd. (INVZ) Reports Q2 Loss, Tops Revenue Estimates
Innoviz Technologies Ltd. (INVZ) Reports Q2 Loss, Tops Revenue Estimates

Innoviz Technologies Ltd. (INVZ) came out with a quarterly loss of $0.06 per share in line with the Zacks Consensus Estimate. This compares to a loss of $0.09 per share a year ago. These figures are

Holley Inc. (HLLY) Q2 Earnings and Revenues Top Estimates
Holley Inc. (HLLY) Q2 Earnings and Revenues Top Estimates

Holley Inc. (HLLY) came out with quarterly earnings of $0.2 per share, beating the Zacks Consensus Estimate of $0.11 per share. This compares to earnings of $0.09 per share a year ago. These figures

Gilat Satellite (GILT) Tops Q2 Earnings Estimates
Gilat Satellite (GILT) Tops Q2 Earnings Estimates

Gilat Satellite (GILT) came out with quarterly earnings of $0.2 per share, beating the Zacks Consensus Estimate of $0.14 per share. This compares to earnings of $0.21 per share a year ago. These

EVgo Inc. (EVGO) Reports Q2 Loss, Tops Revenue Estimates
EVgo Inc. (EVGO) Reports Q2 Loss, Tops Revenue Estimates

EVgo Inc. (EVGO) came out with a quarterly loss of $0.15 per share versus the Zacks Consensus Estimate of a loss of $0.2. This compares to a loss of $0.1 per share a year ago. These figures are

Geron (GERN) Reports Q2 Loss, Beats Revenue Estimates
Geron (GERN) Reports Q2 Loss, Beats Revenue Estimates

Geron (GERN) came out with a quarterly loss of $0.02 per share versus the Zacks Consensus Estimate of a loss of $0.01. This compares to a loss of $0.02 per share a year ago. These figures are

EyePoint (EYPT) Reports Q2 Loss, Beats Revenue Estimates
EyePoint (EYPT) Reports Q2 Loss, Beats Revenue Estimates

EyePoint (EYPT) came out with a quarterly loss of $1.09 per share versus the Zacks Consensus Estimate of a loss of $0.92. This compares to a loss of $0.85 per share a year ago. These figures are

Extreme Networks (EXTR) Q4 Earnings and Revenues Beat Estimates
Extreme Networks (EXTR) Q4 Earnings and Revenues Beat Estimates

Extreme Networks (EXTR) came out with quarterly earnings of $0.32 per share, beating the Zacks Consensus Estimate of $0.29 per share. This compares to earnings of $0.25 per share a year ago. These

Bioventus (BVS) Q2 Earnings Meet Estimates
Bioventus (BVS) Q2 Earnings Meet Estimates

Bioventus (BVS) came out with quarterly earnings of $0.22 per share, in line with the Zacks Consensus Estimate . This compares to earnings of $0.21 per share a year ago. These figures are adjusted

Dine Brands (DIN) Beats Q2 Earnings and Revenue Estimates
Dine Brands (DIN) Beats Q2 Earnings and Revenue Estimates

Dine Brands (DIN) came out with quarterly earnings of $1.16 per share, beating the Zacks Consensus Estimate of $1.04 per share. This compares to earnings of $1.17 per share a year ago. These figures

Charles River Laboratories (CRL) Q2 Earnings and Revenues Surpass Estimates
Charles River Laboratories (CRL) Q2 Earnings and Revenues Surpass Estimates

Charles River Laboratories (CRL) came out with quarterly earnings of $3.02 per share, beating the Zacks Consensus Estimate of $2.72 per share. This compares to earnings of $3.12 per share a year

Brink's (BCO) Q2 Earnings and Revenues Surpass Estimates
Brink's (BCO) Q2 Earnings and Revenues Surpass Estimates

Brink's (BCO) came out with quarterly earnings of $2.13 per share, beating the Zacks Consensus Estimate of $2.05 per share. This compares to earnings of $1.79 per share a year ago. These figures are

BioCryst Pharmaceuticals (BCRX) Tops Q2 Earnings and Revenue EstimatesPhoto, wide shot, wide-angle lens,  Pharmaceutical company, Midday, harsh overhead sunlight, directional sunlightt, photo by Art Wolfe: https://img.midjourneyapi.xyz/temp/7ae4a134-dd01-4c80-a621-18399f5a2541.png
BioCryst Pharmaceuticals (BCRX) Tops Q2 Earnings and Revenue Estimates

BioCryst Pharmaceuticals (BCRX) came out with quarterly earnings of $0.3 per share, beating the Zacks Consensus Estimate of $0.14 per share. This compares to earnings of $0.15 per share a year ago

Advantage Solutions Inc. (ADV) Reports Q2 Loss, Beats Revenue Estimates
Advantage Solutions Inc. (ADV) Reports Q2 Loss, Beats Revenue Estimates

Advantage Solutions Inc. (ADV) came out with a quarterly loss of $3.29 per share versus the Zacks Consensus Estimate of $1.51. This compares to a loss of $0.75 per share a year ago. These figures

Astec Industries (ASTE) Q2 Earnings Miss Estimates
Astec Industries (ASTE) Q2 Earnings Miss Estimates

Astec Industries (ASTE) came out with quarterly earnings of $0.94 per share, missing the Zacks Consensus Estimate of $1.05 per share. This compares to earnings of $0.88 per share a year ago. These